A cancer drug with serious adverse side effects.
Contact Us Now

For a free, confidential
assessment

Votrient Side Effects & Drug Injury Lawsuit

Research shows the anticancer drug pazopanib hydrochloride—sold under the brand name Votrient—might cause deadly side effects such as arterial thrombotic events and congestive heart failure.

What Is Votrient and What Is It Prescribed For?

Votrient is the brand name for the drug pazopanib hydrochloride. Made and sold by the British pharmaceutical company GlaxoSmithKline plc, this prescription medication is used to treat kidney cancer and soft tissue sarcoma. The U.S. Food and Drug Administration (FDA) approved Votrient in October 2009, and GlaxoSmithKline sells it in oral tablets taken daily.

In cancer cells, chemicals called “tyrosine kinases” can promote the cancer’s spread. Votrient is a “tyrosine kinase inhibitor” that interferes with tyrosine kinases’ ability to help kidney and other cancers grow.

Votrient Might Cause Deadly Side Effects

According to research discussed in an article published in the medical journal, Journal of Clinical Oncology, Votrient might cause the following side effects:

  • Arterial thrombotic events;
  • Bleeding;
  • Congestive heart failure; and
  • Liver failure.

Click here to read more about Votrient side effects.

RLG’s Votrient Lawyers Will Make Things Easier

The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again. The Votrient lawyers at the Rottenstein Law Group believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a Votrient lawsuit on your behalf if necessary. RLG will also keep you up to date on any Votrient class action lawsuits, FDA Votrient warnings, and Votrient FDA recall announcements. If you have taken Votrient and believe it harmed you, contact RLG today.

Join the Discussion

Please note: Comments are encouraged in order to permit visitors to discuss relevant topics. Comments are moderated and might be edited by RLG before being published.

Comments should not be used to ask questions of RLG’s lawyers; if you want to speak with a lawyer, please fill out this contact form or call 1 (888) 976-8529. *Your name and email address will not be published.

*

  


six + 1 =

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.